Axsome Therapeutics Inc. trailing returns
Axsome Therapeutics Inc.'s 10-year return is +36.7% a year (CAGR) (+2173.9% cumulative). How Axsome Therapeutics Inc. (AXSM) has performed over the last day, week, month and year, over 5, 10 and 20 years, and since inception, through October 2, 2026 — cumulative and annualized, with dividends on or off.
Trailing returns by period#
To 2026-10-02. Annualized (CAGR) for windows of a year or more.
| Period | Path | Annualized | Cumulative |
|---|---|---|---|
| 1 day | — | -1.6% | |
| 5 days | — | -8.2% | |
| 1 month | — | -14.6% | |
| YTD | — | -1.9% | |
| 1 year | +49.4% | +49.4% | |
| 5 years | +39.2% | +422.7% | |
| 10 years | +36.7% | +2173.9% | |
| Since inception (2015) | +32.0% | +1950.1% |
Growth of AXSM
Actual index level (solid); dashed lines are each window's constant-rate path from start to today.
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-10-02). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Total return reinvests dividends (from AXSM's split- and dividend-adjusted closes); price return excludes them. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Axsome Therapeutics Inc.'s 10-year return?
- Over the last 10 years, Axsome Therapeutics Inc. (AXSM) returned about +36.7% a year annualized (+2173.9% cumulative total return).
- What is Axsome Therapeutics Inc.'s return since inception?
- Since 2015, Axsome Therapeutics Inc. (AXSM) has compounded at about +32.0% a year — +1950.1% in total.